Is tucatinib/tucatinib available in China? what is the price

Tucatinib/Tucatinib, as an oral small molecule drug that specifically inhibits human epidermal growth factor receptor 2 (HER2), is widely used to treat HER2-positive advanced or metastatic breast cancer, as well as unresectable or metastatic colorectal cancer.

HER2, also known as human epidermal growth factor receptor 2, plays a key role in cell growth and development. The unique mechanism of tucatinib is that it can inhibit the overactivity of HER2, cut off its signal transmission to cancer cells, and thereby inhibit the proliferation and spread of cancer cells. It is worth mentioning that tucatinib can also cross the blood-brain barrier and effectively inhibit the metastasis of HER2-positive breast cancer to the brain, which makes the drug show unique efficacy in the treatment of metastatic HER2-positive cancer.

In order to improve the therapeutic effect, tucatinib is often used in combination with anti-cancer drugs such as trastuzumab (Trastuzumab) and chemotherapy drugs. Clinical data show that compared with the traditional trastuzumab plus chemotherapy regimen, the addition of tucatinib can significantly improve the survival time of patients with HER2-positive breast cancer. However, like other drugs, tucatinib may cause side effects such as diarrhea, vomiting, fatigue, and rash. Therefore, patients need to pay close attention to their body's reaction during medication and follow the doctor's instructions for appropriate adjustments and management.

Regarding the price information of tucatinib, since the original version of the drug has not yet been launched in the domestic market, its domestic pricing cannot be obtained. Currently, tucatinib is only available in some overseas markets. For those patients wishing to obtain this medication, it may be necessary to purchase it through overseas channels. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.